Factors influencing malignancy and progression in gliomas include the transforming growth factor-β (TGF-β) signaling pathway, which modulates invasiveness, angiogenesis, immune evasion and stem cell maintenance [2, 3]. The gene discussed is TGFB1; the disease is central nervous system cancer.